So, according to the latest known timeline (not the one on the website), there is a preclinical study ongoing - CHM 2301. Its an Allogeneic CDH17 CORE-NK study - a CAR-NK therapy (I assume) targeting CDH17
... and yes the team need to update the website.... and yes the preclinical data is stellar for Auto CAR T
So, according to the latest known timeline (not the one on the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $27.11K | 6.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 26897271 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 2736030 | 3 |
View Market Depth
| Last trade - 11.20am 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |